Global Flow Diversion Aneurysm Treatment Market 2025-2029

Flow Diversion Aneurysm Treatment Market 2025-2029

The flow diversion aneurysm treatment market is forecasted to grow by USD 2693.9 mn during 2024-2029, accelerating at a CAGR of 9.5% during the forecast period. The report on the flow diversion aneurysm treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of intracranial aneurysms, advancements in flow diverter technology, and minimally invasive treatment.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's flow diversion aneurysm treatment market is segmented as below:

By Product

• FDS
• Intrasaccular flow disruption devices

By End-user

• Hospitals
• Specialty clinics

By Device

• 3.5-5 mm
• 5-7 mm
• Less than 3.5 mm
• More than 7 mm

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing awareness and education as one of the prime reasons driving the flow diversion aneurysm treatment market growth during the next few years. Also, expanding indications of flow diversion procedures and advancements in endovascular technologies will lead to sizable demand in the market.

The report on the flow diversion aneurysm treatment market covers the following areas:

• Flow Diversion Aneurysm Treatment Market sizing
• Flow Diversion Aneurysm Treatment Market forecast
• Flow Diversion Aneurysm Treatment Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading flow diversion aneurysm treatment market vendors that include Acandis GmbH, BALT Group, Evasc Medical Systems Corp., Imperative Care Inc., InNeuroCo, Inspire MD Inc., Lepu Medical Technology Beijing Co. Ltd., Medtronic Plc, Merlin MD Pte. Ltd., MicroPort Scientific Corp., Oxford Endovascular Ltd., Penumbra Inc., phenox GmbH, Rapid Medical Ltd., Stryker Corp., and Terumo Corp.. Also, the flow diversion aneurysm treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.